10 November

Globally, the total confirmed cases of Covid-19 have reached nearly 51 million, with more than 1,263,000 deaths and 33,289,000 recoveries.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The US have the highest number of confirmed cases, forming almost a fifth of all cases worldwide, and is continuing to rise.

The UK has seen a huge increase in cases in the last month, from over 6,000 cases on 1 October to over 23,000 on 1 November, leading the government to initiate a second lockdown to limit spread.

Despite the number of cases being significantly more than ever recorded, deaths are remaining low.

Africa continues to report low numbers of confirmed cases and deaths.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Nigeria, the most populous country in Africa, has over 64,000 confirmed cases and 1,158 deaths. While this in part could be due to low numbers of tests, similar trends are seen all over Africa.

Considering older age is a risk factor for poor prognosis, it must be noted that Africa is the youngest continent, with almost 60% of the population being under 25.

Pharmaceutical developers Pfizer and BioNTech have developed a Covid-19 vaccine that has been tested on over 43,000 participants in various countries with no safety concerns raised.

It is taken in two doses, three weeks apart with 90% protection achieved seven days after the second dose.

However, there is no information as to whether the severity of infections is reduced in vaccinated participants.

Nneoma Okeke MD, Epidemiologist at GlobalData